Rare diseases
Investigational molecules
Locations
Back to Hungary118 clinical trials in Zalaegerszeg, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
HungaryA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
HungaryEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
HungaryEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
HungaryStudy of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)
HungaryA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
HungaryVMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
HungaryNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
HungaryA study to evaluate the safety and how the body processes the combination of ibuprofen and paracetamol in children and adolescents with acute pain
HungaryA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
HungaryStudy of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome
HungaryA study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on atherosclerotic cardiovascular disease and heart conditions. Studies evaluate new treatments for heart failure, stroke prevention, and post-heart attack recovery.
Current trials are investigating medications for hypertrophic cardiomyopathy and post-stroke treatment options.
Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and triple-negative variants. Studies evaluate novel therapeutic approaches.
Multiple trials are exploring new treatment options for various stages of breast cancer.
Research initiatives examining treatments for Type 2 Diabetes and obesity. Studies focus on cardiovascular outcomes and weight management solutions.
Current studies evaluate innovative medications for improved metabolic control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
